biopartnering

Tomorrow 10.45 am GMT, most likely Hammond will present our company to a very illustrous European leadership attending the 18th biopartnering conference, see speakers at conference.

These presentations do, in my humble opinion, not function as a presentation into the unknown but rather as a stepping stone of an already ongoing progress towards active partnering ( only companies which are actively involved in partnering activities in a very promising way would be actually presenting, as only those are of interest to audience ).

OBJ chooses to participate in the UK where Hammond is stationed, GSK has its headquarters as well as one of the FMCG's in all likelihood ( personal assumption ).


We had speculated a month ago that the timing of this conference only days after the 6 months 3M MTA expiry could entail some meaningful events in the making.
The recent frozen shareprice and silence after MTA expiry only supports that notion.

OBJ, in all likelihood, will tick another box towards success at tomorrow's conference.